Zhejiang Sunflower Light Energy (300111) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Sunflower Light Energy (300111) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.42 Million ≈ $354.23K USD) by net assets (CN¥826.15 Million ≈ $120.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Zhejiang Sunflower Light Energy for the company's overall valuation and market capitalisation.
Zhejiang Sunflower Light Energy - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Zhejiang Sunflower Light Energy's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang Sunflower Light Energy Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Sunflower Light Energy ranked by their cash flow conversion efficiency. Explore 300111 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangxi Tianli Technology INC
SHE:300399
|
-0.072x |
|
Fastighetsbolaget Emilshus AB
ST:EMIL-B
|
0.019x |
|
Triveni Engineering & Industries Limited
NSE:TRIVENI
|
0.012x |
|
Shenzhen Jiang and Associates Creative Design Co Ltd
SHE:300668
|
0.019x |
|
Rusoro Mining Ltd
V:RML
|
0.011x |
|
Jiangsu Hanvo Safety Product Co. Ltd.
SHE:300952
|
0.027x |
|
Galiano Gold Inc
TO:GAU
|
0.096x |
|
Regulus Therapeutics Inc
NASDAQ:RGLS
|
-0.154x |
Annual Cash Flow Conversion Efficiency for Zhejiang Sunflower Light Energy (2007–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Sunflower Light Energy from 2007 to 2025. View current stock price of Zhejiang Sunflower Light Energy for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥819.16 Million ≈ $119.87 Million |
CN¥4.20 Million ≈ $614.20K |
0.005x | -86.59% |
| 2024-12-31 | CN¥822.98 Million ≈ $120.43 Million |
CN¥31.44 Million ≈ $4.60 Million |
0.038x | +977.53% |
| 2023-12-31 | CN¥809.53 Million ≈ $118.46 Million |
CN¥2.87 Million ≈ $419.94K |
0.004x | -93.91% |
| 2022-12-31 | CN¥414.84 Million ≈ $60.70 Million |
CN¥24.16 Million ≈ $3.54 Million |
0.058x | -75.93% |
| 2021-12-31 | CN¥410.25 Million ≈ $60.03 Million |
CN¥99.27 Million ≈ $14.53 Million |
0.242x | +23.02% |
| 2020-12-31 | CN¥271.06 Million ≈ $39.66 Million |
CN¥53.31 Million ≈ $7.80 Million |
0.197x | -42.26% |
| 2019-12-31 | CN¥171.75 Million ≈ $25.13 Million |
CN¥58.50 Million ≈ $8.56 Million |
0.341x | -6.55% |
| 2018-12-31 | CN¥177.16 Million ≈ $25.92 Million |
CN¥64.58 Million ≈ $9.45 Million |
0.365x | +132.94% |
| 2017-12-31 | CN¥1.31 Billion ≈ $192.13 Million |
CN¥205.46 Million ≈ $30.07 Million |
0.156x | -44.26% |
| 2016-12-31 | CN¥1.30 Billion ≈ $190.34 Million |
CN¥365.14 Million ≈ $53.43 Million |
0.281x | +57.08% |
| 2015-12-31 | CN¥1.27 Billion ≈ $185.22 Million |
CN¥226.22 Million ≈ $33.10 Million |
0.179x | +90.07% |
| 2014-12-31 | CN¥1.21 Billion ≈ $176.79 Million |
CN¥113.60 Million ≈ $16.62 Million |
0.094x | +56.31% |
| 2013-12-31 | CN¥1.16 Billion ≈ $169.84 Million |
CN¥69.82 Million ≈ $10.22 Million |
0.060x | -83.24% |
| 2012-12-31 | CN¥1.13 Billion ≈ $164.96 Million |
CN¥404.72 Million ≈ $59.22 Million |
0.359x | +362.17% |
| 2011-12-31 | CN¥1.49 Billion ≈ $217.98 Million |
CN¥115.72 Million ≈ $16.93 Million |
0.078x | -45.63% |
| 2010-12-31 | CN¥1.66 Billion ≈ $242.74 Million |
CN¥237.02 Million ≈ $34.68 Million |
0.143x | +6.92% |
| 2009-12-31 | CN¥616.58 Million ≈ $90.23 Million |
CN¥82.39 Million ≈ $12.06 Million |
0.134x | +141.52% |
| 2008-12-31 | CN¥409.97 Million ≈ $59.99 Million |
CN¥-131.96 Million ≈ $-19.31 Million |
-0.322x | +73.14% |
| 2007-12-31 | CN¥103.31 Million ≈ $15.12 Million |
CN¥-123.82 Million ≈ $-18.12 Million |
-1.199x | -- |
About Zhejiang Sunflower Light Energy
Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pne… Read more